Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older
Clinical trial NCT05501522 · COMPLETED
Trial details
- NCT number
- NCT05501522
- Sponsor
- SK Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-09
- Primary completion
- 2023-08-22
- Enrollment
- 840
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.